DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 134 targets from Morgan Stanley. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from Morgan Stanley only. All targets Morgan Stanley’s record →
Morgan Stanley raised its price target on Sherwin-Williams shares (NYSE:SHW) to $395 from $385 while maintaining an Overweight rating on the stock.
Morgan Stanley raised its price target on Seagate Technology shares (NASDAQ:STX) to $1,187 from $1,035 while maintaining an Overweight rating.
Morgan Stanley raised its price target on Nucor (NYSE:NUE) to $270 from $258 while maintaining an Equalweight rating on the steel producer.
Morgan Stanley lowered its price target on Universal Health Services stock (NYSE:UHS) to $191 from $212 while maintaining an Equalweight rating.
Morgan Stanley resumed coverage on Kinetik Holdings, Inc. (NYSE:KNTK) with an overweight rating and a price target of $64.00.
Morgan Stanley downgraded MapLight Therapeutics (NASDAQ:MPLT) to Equalweight from Overweight and lowered its price target to $21.00 from $34.00.
Morgan Stanley raised its price target on Nurix Therapeutics shares (NASDAQ:NRIX) to $38.00 from $36.00
Raised to $650 from $620
Morgan Stanley Raises Verizon Communications (NYSE:VZ) Price Target to $52.00
Morgan Stanley initiated coverage on ITG Inc (NASDAQ:ITG) with an overweight rating and a price target of $19.00.
Morgan Stanley has raised its price target on GE Vernova (NYSE: GEV) from $1,250 to $1,350, maintaining an Overweight rating
Morgan Stanley upgrades Progressive stock rating on underwriting strength
Morgan Stanley downgrades Huntington Bancshares stock rating on deposit pricing pressure
Morgan Stanley upgraded PayPay Corp (NASDAQ:PAYP) to Overweight from Equalweight, while lowering its price target to $23.00 from $24.00.
MS Maintained by Morgan Stanley -- Price Target Raised to $215
Morgan Stanley downgraded Salesforce.com (NYSE:CRM) from Overweight to Equalweight on Tuesday and lowered its price target to $185 from $287.
Morgan Stanley downgraded the shares to underweight from equal weight, slashing its price target to $240 from $365.
Morgan Stanley downgraded Intuit ([NASDAQ:INTU](https://www.investing.com/equities/intuit)) to Equalweight from Overweight and cut its price target to $335 from $580.
Morgan Stanley downgraded Rapid7 (NASDAQ:RPD) to Underweight from Equalweight on Tuesday, setting a price target of $9.00.
Morgan Stanley downgraded PagerDuty (NYSE:PD) to Underweight from Equalweight and lowered its price target to $9.00 from $10.00.
Morgan Stanley downgraded Workday (NASDAQ:WDAY) to Underweight from Equalweight and lowered its price target to $145.00 from $185.00.
TXN Maintained by Morgan Stanley -- Price Target Raised to $230
Morgan Stanley maintained its Overweight rating and $102 price target on the stock.
Overweight rating and $360.00 price target on Apple Inc. (NASDAQ:AAPL)
Upgraded from Equalweight to Overweight; price target raised to $100.00 from $65.00
Morgan Stanley initiated coverage of SpaceX (SPCX) on Tuesday with an Overweight rating and a $300 price target.
UNH Maintained by Morgan Stanley -- Price Target Raised to $529
Morgan Stanley reiterated NVIDIA Corporation as its top semiconductor pick and also maintained a Buy rating with a $288 price target.
Morgan Stanley raised its price target on Tesla to $417 from $415 while maintaining an ‘Equal Weight’ rating.
Morgan Stanley raised its price target on the stock to $468 from $453
Morgan Stanley upgraded Qualcomm (NASDAQ:QCOM) from Underweight to Equalweight ... raised its price target to $231.00 from $146.00
Morgan Stanley Says It’s ‘Time to Act’ on Microsoft as $37 Billion AI Run Rate Fuels $650 Price Target
raised the firm's price target on Chevron Corporation (NYSE:CVX) from $212 to $214, while keeping an 'Overweight' rating
with a price objective of $411.00
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.